Leeward Investments LLC MA Sells 9,669 Shares of Genpact Limited (NYSE:G)

Leeward Investments LLC MA reduced its position in shares of Genpact Limited (NYSE:G - Free Report) by 3.4% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 276,799 shares of the business services provider's stock after selling 9,669 shares during the period. Leeward Investments LLC MA owned about 0.16% of Genpact worth $13,945,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in G. Atlas Capital Advisors Inc. grew its position in shares of Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after buying an additional 216 shares during the period. Stifel Financial Corp grew its position in shares of Genpact by 1.0% during the 4th quarter. Stifel Financial Corp now owns 30,821 shares of the business services provider's stock worth $1,324,000 after buying an additional 291 shares during the period. Fifth Third Bancorp grew its position in shares of Genpact by 9.5% during the 1st quarter. Fifth Third Bancorp now owns 3,461 shares of the business services provider's stock worth $174,000 after buying an additional 299 shares during the period. KBC Group NV grew its position in shares of Genpact by 4.7% during the 1st quarter. KBC Group NV now owns 7,266 shares of the business services provider's stock worth $366,000 after buying an additional 324 shares during the period. Finally, OneAscent Wealth Management LLC grew its position in shares of Genpact by 5.5% during the 4th quarter. OneAscent Wealth Management LLC now owns 8,380 shares of the business services provider's stock worth $360,000 after buying an additional 439 shares during the period. 96.03% of the stock is owned by institutional investors.

Genpact Trading Up 2.1%

NYSE G traded up $0.93 on Friday, hitting $45.92. The company's stock had a trading volume of 1,088,830 shares, compared to its average volume of 1,409,984. The company has a quick ratio of 2.45, a current ratio of 2.45 and a debt-to-equity ratio of 0.48. Genpact Limited has a 1-year low of $30.38 and a 1-year high of $56.76. The company's 50-day moving average is $44.31 and its 200 day moving average is $46.96. The firm has a market cap of $8.03 billion, a PE ratio of 15.67, a PEG ratio of 2.00 and a beta of 0.94.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. The company had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.21 billion. Genpact had a net margin of 10.88% and a return on equity of 22.35%. Genpact's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.73 earnings per share. As a group, analysts predict that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Wednesday, June 18th were paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date of this dividend was Wednesday, June 18th. Genpact's dividend payout ratio (DPR) is 23.21%.

Insider Buying and Selling at Genpact

In other news, Director Nicholas C. Gangestad purchased 2,000 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The shares were bought at an average cost of $43.97 per share, with a total value of $87,940.00. Following the completion of the transaction, the director directly owned 2,000 shares of the company's stock, valued at approximately $87,940. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 3.07% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Robert W. Baird lowered their price target on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Wall Street Zen upgraded shares of Genpact from a "buy" rating to a "strong-buy" rating in a research report on Friday, June 6th. Needham & Company LLC restated a "buy" rating and set a $50.00 price objective on shares of Genpact in a report on Monday, June 30th. Finally, Mizuho lifted their price target on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 1st. Four equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $50.14.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.